Literature DB >> 32686551

Polysubstance Use Patterns among Justice-Involved Individuals Who Use Opioids.

Amanda M Bunting1, Carrie Oser1,2, Michele Staton2,3, Hannah Knudsen2,3.   

Abstract

AIM: The current study explores pre-incarceration polysubstance use patterns among a justice-involved population who use opioids. Design: Setting: Data from prison and jail substance use programing in the state of Kentucky from 2015-2017 was examined. Participants: A cohort of 6,569 individuals who reported both pre-incarceration use of opioids and reported the use of more than one substance per day. Measurements: To determine the different typologies of polysubstance use involving opioids, latent profile analysis of the pre-incarceration thirty-day drug use of eight substances was conducted. Multinomial logistic regression predicted latent profile membership. Findings: Six unique profiles of polysubstance use involving opioids and other substances were found; Primarily Alcohol (9.4%), Primarily Heroin (19.0%), Less Polysubstance Use (34.3%), Tranquilizer Polysubstance Use (16.3%), Primarily Buprenorphine (7.8%), and Stimulant-Opioid (13.2%). Profiles differed by rural/urban geography, injection drug use, physical, and mental health symptoms.
Conclusion: Findings indicate the heterogeneity of opioid use among a justice-involved population. More diverse polysubstance patterns may serve as a proxy to identifying individuals with competing physical and mental health needs. Future interventions could be tailored to polysubstance patterns during the period of justice-involvement.

Entities:  

Keywords:  Opioid; criminal justice; latent profile analysis; polysubstance use

Mesh:

Substances:

Year:  2020        PMID: 32686551      PMCID: PMC7484418          DOI: 10.1080/10826084.2020.1795683

Source DB:  PubMed          Journal:  Subst Use Misuse        ISSN: 1082-6084            Impact factor:   2.164


  42 in total

1.  Using latent class analysis (LCA) to analyze patterns of drug use in a population of illegal opioid users.

Authors:  Neerav Monga; Jürgen Rehm; Benedikt Fischer; Suzanne Brissette; Julie Bruneau; Nady El-Guebaly; Lina Noël; Mark Tyndall; Cameron Wild; Francesco Leri; Jean-Sébastien Fallu; Saira Bahl
Journal:  Drug Alcohol Depend       Date:  2006-10-17       Impact factor: 4.492

2.  Understanding the rural-urban differences in nonmedical prescription opioid use and abuse in the United States.

Authors:  Katherine M Keyes; Magdalena Cerdá; Joanne E Brady; Jennifer R Havens; Sandro Galea
Journal:  Am J Public Health       Date:  2013-12-12       Impact factor: 9.308

3.  The effects of dronabinol during detoxification and the initiation of treatment with extended release naltrexone.

Authors:  Adam Bisaga; Maria A Sullivan; Andrew Glass; Kaitlyn Mishlen; Martina Pavlicova; Margaret Haney; Wilfrid N Raby; Frances R Levin; Kenneth M Carpenter; John J Mariani; Edward V Nunes
Journal:  Drug Alcohol Depend       Date:  2015-07-08       Impact factor: 4.492

4.  Subtypes of nonmedical opioid users: results from the national epidemiologic survey on alcohol and related conditions.

Authors:  Li-Tzy Wu; George E Woody; Chongming Yang; Dan G Blazer
Journal:  Drug Alcohol Depend       Date:  2010-07-01       Impact factor: 4.492

5.  Differences in polysubstance use patterns and drug-related outcomes between people who inject drugs receiving and not receiving opioid substitution therapies.

Authors:  Kim S Betts; Gary Chan; Fairlie McIlwraith; Paul Dietze; Elizabeth Whittaker; Lucy Burns; Rosa Alati
Journal:  Addiction       Date:  2016-04-03       Impact factor: 6.526

6.  Cue exposure with coping skills training and communication skills training for alcohol dependence: 6- and 12-month outcomes.

Authors:  D J Rohsenow; P M Monti; A V Rubonis; S B Gulliver; S M Colby; J A Binkoff; D B Abrams
Journal:  Addiction       Date:  2001-08       Impact factor: 6.526

7.  OxyContin® as currency: OxyContin® use and increased social capital among rural Appalachian drug users.

Authors:  Adam B Jonas; April M Young; Carrie B Oser; Carl G Leukefeld; Jennifer R Havens
Journal:  Soc Sci Med       Date:  2012-03-08       Impact factor: 4.634

8.  Clinician identified barriers to treatment for individuals in Appalachia with opioid use disorder following release from prison: a social ecological approach.

Authors:  Amanda M Bunting; Carrie B Oser; Michele Staton; Katherine S Eddens; Hannah Knudsen
Journal:  Addict Sci Clin Pract       Date:  2018-12-03

9.  Opportunities to Prevent Overdose Deaths Involving Prescription and Illicit Opioids, 11 States, July 2016-June 2017.

Authors:  Christine L Mattson; Julie O'Donnell; Mbabazi Kariisa; Puja Seth; Lawrence Scholl; R Matthew Gladden
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2018-08-31       Impact factor: 17.586

View more
  3 in total

Review 1.  Patterns and motivations of polysubstance use: a rapid review of the qualitative evidence.

Authors:  Michèle Boileau-Falardeau; Gisèle Contreras; Geneviève Gariépy; Claudie Laprise
Journal:  Health Promot Chronic Dis Prev Can       Date:  2022-02       Impact factor: 3.240

2.  Profiles of lifetime substance use are differentiated by substance of choice, affective motivations for use, and childhood maltreatment.

Authors:  Naomi Sadeh; Rickie Miglin; Nadia Bounoua; Emil Beckford; Suzanne Estrada; Arielle Baskin-Sommers
Journal:  Addict Behav       Date:  2020-10-14       Impact factor: 3.913

3.  Pre-incarceration polysubstance use involving opioids: A unique risk factor of postrelease return to substance use.

Authors:  Amanda M Bunting; Carrie B Oser; Michele Staton; Hannah K Knudsen
Journal:  J Subst Abuse Treat       Date:  2021-03-05
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.